In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second largest influenza vaccine company in the world. Read More
CSL Facility on the Front Line of Flu Fight
The Kankakee, IL facility and its flu vaccine preparations were the feature of a recent Chicago news program.
Seqirus receives FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
Seqirus announced today that the US Food and ...
Seqirus to highlight new data in seasonal influenza prevention at Options IX for the Control of Influenza conference
Seqirus announced today that seven poster ...
Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children
Seqirus today announced results of two data ...
Seqirus now shipping its complete portfolio of seasonal influenza vaccines to US market for the 2016-2017 season
Seqirus is now shipping its complete portfolio...
Search Career Opportunities
At Seqirus, each employee has the opportunity to play a role in improving people's health.